| Literature DB >> 33119634 |
Ann-Sofie Sundman1, Fábio Pértille1,2, Luiz Lehmann Coutinho2, Elena Jazin3, Carlos Guerrero-Bosagna1, Per Jensen1.
Abstract
Epigenetic factors such as DNA methylation act as mediators in the interaction between genome and environment. Variation in the epigenome can both affect phenotype and be inherited, and epigenetics has been suggested to be an important factor in the evolutionary process. During domestication, dogs have evolved an unprecedented between-breed variation in morphology and behavior in an evolutionary short period. In the present study, we explore DNA methylation differences in brain, the most relevant tissue with respect to behavior, between wolf and dog breeds. We optimized a combined method of genotype-by-sequencing (GBS) and methylated DNA immunoprecipitation (MeDIP) for its application in canines. Genomic DNA from the frontal cortex of 38 dogs of 8 breeds and three wolves was used. GBS and GBS-MeDIP libraries were prepared and sequenced on Illuma HiSeq2500 platform. The reduced sample represented 1.18 ± 0.4% of the total dog genome (2,4 billion BP), while the GBS-MeDIP covered 11,250,788 ± 4,042,106 unique base pairs. We find substantial DNA methylation differences between wolf and dog and between the dog breeds. The methylation profiles of the different groups imply that epigenetic factors may have been important in the speciation from dog to wolf, but also in the divergence of different dog breeds. Specifically, we highlight methylation differences in genes related to behavior and morphology. We hypothesize that these differences are involved in the phenotypic variation found among dogs, whereas future studies will have to find the specific mechanisms. Our results not only add an intriguing new dimension to dog breeding but are also useful to further understanding of epigenetic involvement.Entities:
Mesh:
Year: 2020 PMID: 33119634 PMCID: PMC7595415 DOI: 10.1371/journal.pone.0240787
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Average coverage for GBS and GBS-MeDIP for all samples.
| GBS | GBS-MeDIP | |||||||
|---|---|---|---|---|---|---|---|---|
| Depth | BP seq | Breadth | % | Depth | BP seq | Breadth | % | |
| Beagle | 31.6 | 998,800,150 | 29,853,945 | 1.25 | 43.9 | 527,827,555 | 11,819,563 | 0.49 |
| Boxer | 29.6 | 614,887,698 | 20,763,844 | 0.87 | 33.2 | 243,807,962 | 7,359,138 | 0.31 |
| German sh. | 30.5 | 673,323,948 | 20,019,369 | 0.84 | 40.8 | 295,928,883 | 7,123,554 | 0.30 |
| Great Dane | 40.1 | 996,421,318 | 24,141,234 | 1.01 | 45.2 | 449,581,812 | 9,504,467 | 0.40 |
| Labrador | 22.5 | 494,016,535 | 21,733,556 | 0.91 | 24.8 | 230,979,636 | 9,477,432 | 0.40 |
| Pitbull | 38.5 | 1,593,561,439 | 34,791,126 | 1.45 | 53.4 | 923,696,054 | 15,236,931 | 0.64 |
| Rottweiler | 31.9 | 1,068,933,565 | 31,149,168 | 1.30 | 52.0 | 576,496,251 | 10,710,978 | 0.45 |
| Walker | 34.3 | 1,325,354,578 | 33,115,536 | 1.38 | 50.9 | 743,542,862 | 13,849,098 | 0.58 |
| Wolf | 22.2 | 616,700,033 | 25,718,629 | 1.07 | 33.9 | 339,433,286 | 8,922,769 | 0.37 |
BP seq = base pair sequenced
Breadth = depth/BP seq
% = percent of whole genome
Fig 1Neighbour-joining tree based on SNPs in the GBS reduced genome.
Although only a reduced representation sample was used, individuals from the same species/breed group together, except two outliers (one Labrador (turquoise) and one walker hound (grey)).
The number of differences in allele changes (SNPs fixed within species and breeds) between compared groups.
| Wolf | Beagle | Boxer | GSD | Great D. | Labrador | Pitbull | Rottw. | Walker | |
|---|---|---|---|---|---|---|---|---|---|
| Wolf | - | 1342 | 2940 | 1920 | 1374 | 1613 | 943 | 1779 | 745 |
| Beagle | - | 844 | 406 | 139 | 283 | 62 | 283 | 19 | |
| Boxer | - | 1603 | 821 | 1177 | 313 | 1273 | 288 | ||
| GSD | - | 434 | 668 | 210 | 638 | 139 | |||
| Great D. | - | 316 | 68 | 295 | 32 | ||||
| Labrador | - | 116 | 456 | 75 | |||||
| Pitbull | - | 126 | 7 | ||||||
| Rottw. | - | 90 | |||||||
| Walker | - |
GSD: German shepherd dog
Fig 2Differentially methylated regions (DMRs) between wolf and dog.
a) Manhattan plot of DMRs between wolf and dogs. Line represents p<0.0005 cutoff. b) Volcano plot with DMRs for wolf and dogs. c) Pie chart of in what sequence variant DMRs p<0.005 are located in relation to the closest gene. d) Volcano plots with DMRs from analyses between wolf and each breed. For both a) and d), DMRs with negative log fold change are hypomethylated in the wolf and DMRs with positive log fold change are hypermethylated.
List of genes with significant DMRs between wolf and dogs and wolf and breeds.
Location is presented as chromosome:start-stop and adjacent regions have been merged. Strand is indicated by 1 or -1. Significant DMRs in intergenic regions are not included. P<0.0005 is considered significant.
| Comp-arison | Location | Position | Gene (Ensmbl) | Symbol | Gene name | |
|---|---|---|---|---|---|---|
| 4:3859701–3860000 | -1 | Intron | ENSCAFG00000011101 | GPR137B | G protein-coupled receptor 137B | |
| 5:38033301–38033800 | 1 | Intron | ENSCAFG00000028975 | HS3ST3B1 | Sulfotransferase | |
| 5:58084401–58084800 | -1 | Intron | ENSCAFG00000019477 | MEGF6 | Multiple EGF Like Domains 6 | |
| 9:860301–860500 | 1 | Intron | ENSCAFG00000005719 | TEPSIN | Adaptor related protein complex 4 | |
| 10:16973601–16973900 | 1 | Coding seq. | ENSCAFG00000000673 | PLXNB2 | Plexin B2 | |
| 10:29677701–29678100 | -1 | Intron | ENSCAFG00000038553 | - | ||
| 10:454201–454800 | 1 | Intron | ENSCAFG00000000108 | ESYT1 | Extended synaptotagmin 1 | |
| 16:1003001–1003300 | -1 | Downstream | ENSCAFG00000034234 | - | ||
| 17:40393501–40393800 | 1 | Intron | ENSCAFG00000007987 | SUCLG1 | Succinate—CoA ligase [ADP/GDP-forming] subunit alpha | |
| 20:39424401–39424800 | 1 | Coding seq. | ENSCAFG00000011008 | CAMKV | CaM kinase like vesicle | |
| 24:42506201–42506501 | -1 | Intron | ENSCAFG00000012058 | CTCFL | CCCTC-binding factor like | |
| 1:93322101–93322600 | 1 | 5’ UTP | ENSCAFG00000002102 | JAK2 | Tyrosine-protein kinase | |
| 1:93322101–93322600 | -1 | Upstream | ENSCAFG00000039255 | - | ||
| 25:48720101–48720500 | -1 | Intron | ENSCAFG00000012433 | PER2 | Period circadian clock 2 | |
| 7:67036001–67036140 | 1 | Coding seq. | ENSCAFG00000018309 | USP14 | Ubiquitin specific peptidase 14 | |
| 7:67036001–67036140 | 1 | Downstream | ENSCAFG00000018282 | ROCK1 | Rho-associated protein kinase | |
| 8:986301–986700 | -1 | Intron | ENSCAFG00000010820 | CATSPERB | Cation channel sperm associated auxiliary subunit beta | |
| 14:20122501–20123000 | 1 | Intron | ENSCAFG00000032379 | PEG10 | Paternally Expressed 10 | |
| 14:20122501–20123000 | -1 | Upstream | ENSCAFG00000002104 | SGCE | Sarcoglycan epsilon | |
| 30:39272601–39273000 | -1 | Coding seq. | ENSCAFG00000018073 | PSTPIP1 | Proline-serine-threonine phosphatase interacting protein 1 | |
| 36:18696701–18696800 | -1 | Intron | ENSCAFG00000013271 | WIPF1 | WAS/WASL Interacting Protein Family Member 1 | |
| 9:2860101–2860300 | -1 | Intron | ENSCAFG00000005312 | PGS1 | CDP-diacylglycerol—glycerol-3-phosphate 3-phosphatidyltransferase | |
| 9:2860101–2860300 | 1 | Downstream | ENSCAFG00000005306 | SOCS3 | Suppressor of cytokine-signaling 3 | |
| 21:35980601–35981000 | 1 | Downstream | ENSCAFG00000008082 | RASSF10 | Ras association domain family member 10 | |
| 18:52431001–52431600 | 1 | Downstream | ENSCAFG00000014309 | RASGRP2 | RAS guanyl releasing protein 2 | |
| 4:34785701–34786100 | -1 | Intron | ENSCAFG00000016100 | SYT15/LOC489080 | Synaptotagmin 15 | |
| 4:34785701–34786100 | -1 | Downstream | ENSCAFG00000016101 | GPRIN2 | G protein regulated inducer of neurite outgrowth 2 | |
| 9:40807801–40808200 | -1 | Coding seq. | ENSCAFG00000018462 | RNF135 | Ring finger protein 135 |
GSD: German shepherd dog
Results from the gene ontology (GO) enrichment analysis for DMRs between wolf and dog.
Go terms for biological process and molecular function with p-values <0.05 are presented. No Go terms for cellular component reached significance. Observed (O), expected (E), ratio O/E (R), p-value (p), and false discovery rate (FDR) are show for each term, as well as the contributing genes.
| GO term | Description | O | E | R | p | FDR | Genes | |
|---|---|---|---|---|---|---|---|---|
| GO:0007389 | pattern specification process | 5 | 1,0 | 5,1 | <0,01 | 0,79 | HOXD10, ACVRL1, HOXA11, HES4, GRHL3 | |
| GO:0051960 | regulation of nervous system development | 6 | 1,7 | 3,6 | 0,01 | 0,79 | AMIGO3, EFNA1, ULK4, HES4, GDI1, GRHL3 | |
| GO:0009790 | embryo development | 7 | 2,3 | 3,1 | 0,01 | 0,79 | HOXD10, EFNA1, ACVRL1, HOXA11, HES4, COL6A1, GRHL3 | |
| GO:0050803 | regulation of synapse structure or activity | 3 | 0,5 | 6,2 | 0,01 | 1,00 | CAMKV, AMIGO3, EFNA1 | |
| GO:0022603 | regulation of anatomical structure morphogenesis | 6 | 2,0 | 3,0 | 0,01 | 1,00 | EFNA1, ACVRL1, PDZD8, HOXA11, GDI1, GRHL3 | |
| GO:0022406 | membrane docking | 2 | 0,2 | 10,3 | 0,02 | 1,00 | EXOC6B, PDZD8 | |
| GO:0060284 | regulation of cell development | 5 | 1,6 | 3,1 | 0,02 | 1,00 | EFNA1, ULK4, HOXA11, HES4, GDI1 | |
| GO:0009887 | animal organ morphogenesis | 6 | 2,3 | 2,7 | 0,02 | 1,00 | HOXD10, EFNA1, ACVRL1, HOXA11, COL6A1, GRHL3 | |
| GO:0051640 | organelle localization | 4 | 1,2 | 3,4 | 0,03 | 1,00 | CCNB1, EXOC6B, PDZD8, NDC80 | |
| GO:0048646 | anatomical structure formation involved in morphogenesis | 6 | 2,4 | 2,5 | 0,03 | 1,00 | EFNA1, ACVRL1, HOXA11, HES4, COL6A1, GRHL3 | |
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 7 | 2,2 | 3,1 | 0,01 | 0,64 | ULK4, CCNB1, SUCLG1, CAMKV, ADK, AK1, ACVRL1 | |
| GO:0019838 | growth factor binding | 2 | 0,3 | 6,2 | 0,04 | 1,00 | COL6A1, ACVRL1 | |
| GO:0030234 | enzyme regulator activity | 5 | 2,0 | 2,5 | 0,05 | 1,00 | CCNB1, CAST, ITIH1, GDI1, PHACTR3 |
Results from the pathway analysis based on DMRs between wolf and dog.
Reactome pathway name and description are presented. Pathway hierarchy represents the highest hierarchy branches for the pathways. P-value (p), false discovery rate (FDR), and contibuting genes are shown.
| Pathway | Description | p | FDR | Pathway hierarchy | Genes |
|---|---|---|---|---|---|
| R-CFA-399954 | Sema3A PAK dependent Axon repulsion | 0,01 | 0,38 | Developmental biology—axon guidance | PLXNA3 |
| R-CFA-399955 | SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | <0,01 | 0,25 | Developmental biology—axon guidance | PLXNA3 |
| R-CFA-399956 | CRMPs in Sema3A signaling | 0,01 | 0,38 | Developmental biology—axon guidance | PLXNA3 |
| R-CFA-203927 | MicroRNA (miRNA) biogenesis | 0,01 | 0,41 | Gene expression—gene silencing | PRKRA |
| R-CFA-426486 | Small interfering RNA (siRNA) biogenesis | 0,02 | 0,43 | Gene expression—gene silencing | PRKRA |
| R-CFA-1236973 | Cross-presentation of particulate exogenous antigens (phagosomes) | 0,02 | 0,43 | Immune response—adaptive | ITGB5 |
| R-CFA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 0,04 | 0,43 | Immune response—innate | IKBKG |
| R-CFA-5684264 | MAP3K8 (TPL2)-dependent MAPK1/3 activation | 0,04 | 0,43 | Immune response—innate | IKBKG |
| R-CFA-937039 | IRAK1 recruits IKK complex | 0,05 | 0,43 | Immune response—innate | IKBKG |
| R-CFA-975144 | IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 0,05 | 0,43 | Immune response—innate | IKBKG |
| R-CFA-5661270 | Formation of xylulose-5-phosphate | 0,01 | 0,30 | Metabolism—carbohydrates | DCXR |
| R-CFA-1855167 | Synthesis of pyrophosphates in the cytosol | 0,03 | 0,43 | Metabolism—inositol phosphate | IP6K1 |
| R-CFA-1855191 | Synthesis of IPs in the nucleus | <0,01 | 0,19 | Metabolism—inositol phosphate | IP6K1 |
| R-CFA-428157 | Sphingolipid metabolism | 0,05 | 0,43 | Metabolism—lipids | CERS2, ESYT1, GLB1L |
| R-CFA-4755510 | SUMOylation of immune response proteins | 0,01 | 0,38 | Metabolism of proteins | IKBKG |
| R-CFA-75893 | TNF signaling | <0,01 | 0,04 | Signal transduction—death receptor signaling | TRAF1, IKBKG, SHARPIN |
| R-CFA-2428933 | SHC-related events triggered by IGF1R | <0,01 | 0,04 | Signal transduction—IGF1R signaling | IGF2 |
Fig 3Differentially methylated regions (DMRs) between breeds.
a) Volcano plot for each breed comparison where the vertical was compared to the horizontal (left to right). Thus, DMRs with negative log fold change are hypomethylated in the vertical and DMRs with positive log fold change are hypermethylated. b) The number of DMRs (p<0.05) for each breed from the breed comparisons. Colors indicate number of DMRs with positive (red) versus negative (blue) log fold change. (GSD: German shepherd dog).
Fig 4Differentially methylated regions (DMRs) between female and male dogs.
a) Manhattan plot of DMRs between female and male dogs. Line represents p<0.0005 cutoff. b) Volcano plot with DMRs for female and male dogs. DMRs with negative log fold change are hypomethylated in females and DMRs with positive log fold change are hypermethylated. c) Pie chart of in what sequence variant DMRs p<0.005 are located in relation to the closest gene.